Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597740 · ClinicalTrials.gov registry record
Propofol Sedation Study
A clinical trial, sponsored by Scottsdale Healthcare.
- Completed
- Registry status
- 57
- Enrollment target
NCT00597740: Completed study, sponsored by Scottsdale Healthcare.
NCT00597740 is a clinical trial that has completed, run by Scottsdale Healthcare. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597740 has completed, sponsored by Scottsdale Healthcare.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
Purpose of Protocol: The purpose of this study will be to compare the clinical utility of Propofol sedation with and without the use of the ICU Sedation Protocol. Patients will be treated according to the attending/consulting preference. No attempt will be made to influence the patient's routine care and management. The study will compare the average hourly infusion rates for the Propofol administration, as well as obtain the nursing staffs evaluation regarding the ease of neurological assessment during each 12 hour shift
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-12 |
What the finished NCT00597740 record still lists
NCT00597740 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00597740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00597740 about?
NCT00597740 is a clinical study titled "Propofol Sedation Study". Purpose of Protocol: The purpose of this study will be to compare the clinical utility of Propofol sedation with and without the use of the ICU Sedation Protocol. Patients will be treated according to the attending/consulting preference. No attempt will be made to influence the patient's routine car...
What is the current status of trial NCT00597740?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2007-12. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00597740?
This trial is sponsored by Scottsdale Healthcare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia